Recent advances in the microbial hydroxylation and reduction of soy isoflavones

FEMS Microbiology Letters

Volumn 365, Issue 19, 2018, Pages

  Lee, Pyung Gang ^a   Lee, Uk Jae ^a   Song, Hanbit ^a   Choi, Kwon Young ^b   Kim, Byung Gee ^a  

^a Seoul National University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Equol; Isoflavone derivatives; Microbial fermentation; Ortho dihydroxyisoflavone; Whole cell biotransformation

Indexed keywords

EQUOL; ISOFLAVONE DERIVATIVE;

BACTERIUM; BIOSYNTHESIS; CHEMISTRY; HUMAN; HYDROXYLATION; METABOLISM; OXIDATION REDUCTION REACTION; SOYBEAN;

BACTERIA; EQUOL; HUMANS; HYDROXYLATION; ISOFLAVONES; OXIDATION-REDUCTION; SOYBEANS;

EID: 85054132588     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fny195     Document Type: Review

References (124)

1. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998;356:133-41.
2. Braune A, Blaut M. Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ Microbiol 2011;13:482-94.
3. Braune A, Blaut M. Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C-and O-glucosides. Appl Environ Microb 2012;78:8151-3.
4. Cao H, Chen X, Jassbi AR et al. Microbial biotransformation of bioactive flavonoids. Biotechnol Adv 2015;33:214-23.
5. Chang T-S. Two potent suicide substrates of mushroom tyrosinase: 7, 8, 4'-trihydroxyisoflavone and 5, 7, 8, 4'-tetrahydroxyisoflavone. J Agric Food Chem 2007;55:2010- 5.
6. Chang T-S. Isolation, bioactivity, and production of orthohydroxydaidzein and ortho-hydroxygenistein. Int J Mol Sci 2014;15:5699-716.
7. Chang T-S, Chao S-Y, Chen Y-C. Production of orthohydroxydaidzein derivatives by a recombinant strain of Pichia pastoris harboring a cytochrome P450 fusion gene. Process Biochem 2013;48:426-9.
8. Chang T-S, Ding H-Y, Lin H-C. Identifying 6,7,4'-trihydroxyisoflavone as a potent tyrosinase inhibitor. Biosci Biotech Bioch 2005;69:1999-2001.
9. Chen Y-C, Sugiyama Y, Abe N et al. DPPH radical-scavenging compounds from dou-chi, a soybean fermented food. Biosci Biotech Bioch 2005;69:999-1006.
10. Chiang C-M, Ding H-Y, Lu J-Y et al. Biotransformation of isoflavones daidzein and genistein by recombinant Pichia pastoris expressing membrane-anchoring and reductase fusion chimeric CYP105D7. J Taiwan Inst Chem Eng 2016;60:26- 31.
11. Chiang C-M, Wang D-S, Chang T-S. Improving free radical scavenging activity of soy isoflavone glycosides daidzin and genistin by 3'-hydroxylation using recombinant Escherichia coli. Molecules 2016;21:1723.
12. Choi KY, Jung E, Jung DH et al. Cloning, expression and characterization of CYP102D1, a self-sufficient P450 monooxygenase from Streptomyces avermitilis. FEBS J 2012a;279:1650-62.
13. Choi K-Y, Jung E, Jung D-H et al. Engineering of daidzein 3'-hydroxylase P450 enzyme into catalytically self-sufficient cytochrome P450. Microb Cell Fact 2012b;11:81.
14. Choi KY, Jung EO, Yun H et al. Development of colorimetric HTS assay of cytochrome p450 for ortho-specific hydroxylation, and engineering of CYP102D1 with enhanced catalytic activity and regioselectivity. ChemBioChem 2013;14:1231-8.
15. Choi K-Y, Jung E, Yun H et al. Engineering class I cytochrome P450 by gene fusion with NADPH-dependent reductase and S. avermitilis host development for daidzein biotransformation. Appl Microbiol Biot 2014;98:8191-200.
16. Choi KY, Kim Tj, Koh SK et al. A-ring ortho-specific monohydroxylation of daidzein by cytochrome P450s of Nocardia farcinica IFM10152. Biotechnol J 2009;4:1586-95.
17. Choi K-Y, Park H-Y, Kim B-G. Characterization of bi-functional CYP154 from Nocardia farcinica IFM10152 in the Odealkylation and ortho-hydroxylation of formononetin. Enzyme Microb Technol 2010;47:327-34.
18. Choi K-Y, Yang Y-H, Kim B-G. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-orthodihydroxyisoflavone. Enzyme Microb Technol 2015;71:20-27.
19. Ding H-Y, Chiang C-M, Tzeng W-M et al. Identification of 3_-hydroxygenistein as a potent melanogenesis inhibitor from biotransformation of genistein by recombinant Pichia pastoris. Process Biochem 2015;50:1614-7.
20. Esaki H, Kawakishi S, Morimitsu Y et al. New potent antioxidative o-dihydroxyisoflavones in fermented Japanese soybean products. Biosci Biotech Bioch 1999a;63:1637-9.
21. Esaki H, Onozaki H, Morimitsu Y et al. Potent antioxidative isoflavones isolated from soybeans fermented with Aspergillus saitoi. Biosci Biotech Bioch 1998;62:740-6.
22. Esaki H, Watanabe R, Onozaki H et al. Formation mechanism for potent antioxidative o-dihydroxyisoflavones in soybeans fermented with Aspergillus saitoi. Biosci Biotech Bioch 1999b;63:851-8.
23. Frankenfeld CL. O-desmethylangolensin: The importance of equol's lesser known cousin to human health. Adv Nutr 2011;2:317-24.
24. Funaki A, Waki T, Noguchi A et al. Identification of a highly specific isoflavone 7-O-glucosyltransferase in the soybean (Glycine max (L.) Merr.). Plant Cell Physiol 2015;56:1512-20.
25. Funayama S, Anraku Y, Mita A et al. Structural study of isoflavonoids possessing antioxidant activity isolated from the fermentation broth of Streptomyces sp. J Antibiot 1989;42:1350-5.
26. Gao YN, Hao QH, Zhang HL et al. Reduction of soy isoflavones by use of Escherichia coli whole-cell biocatalyst expressing isoflavone reductase under aerobic conditions. Lett Appl Microbiol 2016;63:111-6.
27. Gardana C, Canzi E, Simonetti P. R(-)-O-desmethylangolensin is the main enantiomeric form of daidzein metabolite produced by human in vitro and in vivo. J Chromatogr B 2014;953-954:30-7.
28. Gaya P, Peirotén Á, Álvarez I et al. Production of the bioactive isoflavone O -desmethylangolensin by Enterococcus faecium INIA P553 with high efficiency. J Funct Foods 2018;40:180-6.
29. Gaya P, Peirotén Á, Landete JM. Transformation of plant isoflavones into bioactive isoflavones by lactic acid bacteria and bifidobacteria. J Funct Foods 2017;39:198-205.
30. György P, Murata K, Ikehata H. Antioxidants isolated from fermented soybeans (tempeh). Nature 1964;203:870-2.
31. Hatakeyama M, Kitaoka T, Ichinose H. Impacts of amino acid substitutions in fungal cytochrome P450 monooxygenase (CYP57B3) on the effective production of 3'-hydroxygenistein. FEMS Microbiol Lett 2017;364, doi: 10.1093/femsle/fnx107.
32. Hirota A, Inaba M, Chen Y-C et al. Isolation of 8-hydroxyglycitein and 6-hydroxydaidzein from soybean miso. Biosci Biotech Bioch 2004;68:1372-4.
33. Hur H-G, Beger RD, Heinze TM et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch Microbiol 2002;178:8-12.
34. Hwang CS, Kwak HS, Lim HJ et al. Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 2006;101:246-53.
35. Ikehata H, Wakaizumi M, Murata K. Antioxidant and antihemolytic activity of a new isoflavone,"Factor 2" isolated from tempeh. Agric Biol Chem 1968;32:740-6.
36. Itsumi M, Shiota M, Takeuchi A et al. Equol inhibits prostate cancer growth through degradation of androgen receptor by Sphase kinase-associated protein 2. Cancer Sci 2016;107:1022- 8.
37. Jackson RL, Greiwe JS, Schwen RJ. Emerging evidence of the health benefits of S-equol, an estrogen receptor beta agonist. Nutr Rev 2011;69:432-48.
38. Jin J-S, Nishihata T, Kakiuchi N et al. Biotransformation of Cglucosylisoflavone puerarin to estrogenic (3S)-equol in coculture of two human intestinal bacteria. Biol Pharm Bull 2008;31:1621-5.
39. Jou H-J, Tsai P-J, Tu J-H et al. Stinky tofu as a rich source of bioavailable S-equol in Asian diets. J Funct Foods 2013;5:651-9.
40. Kawada Y, Yokoyama S, Yanase E et al. The production of Sequol from daidzein is associated with a cluster of three genes in Eggerthella sp. YY7918. Biosci Microbiota Food Health 2016;35:113-21.
41. Kim H, Kim JR, Kang H et al. 7,8,4'-trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PLoS One 2014;9:e104938.
42. Kim M, Han J. Chiroptical study and absolute configuration of (-)-O-DMA produced from daidzein metabolism. Chirality 2014;26:434-7.
43. Kim M, Marsh EN, Kim SU et al. Conversion of (3S,4R)-tetrahydrodaidzein to (3S)-equol by THD reductase: Proposed mechanism involving a radical intermediate. Biochemistry 2010;49:5582-7.
44. Klus K, BarzW. Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe. Arch Microbiol 1995;164:428-34.
45. Ko S, Yang Y-H, Choi K-Y et al. Rational design and directed evolution of CYP102A1 (BM3) for regio-specific hydroxylation of isoflavone. Biotechnol Bioproc E 2015;20:225-33.
46. Komiyama K, Funayama S, Anraku Y et al. Isolation of isoflavonoids possessing antioxidant activity from the fermentation broth of Streptomyces sp. J Antibiot 1989;42: 1344-9.
47. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-63.
48. Kwon JE, Lim J, Kim I et al. Isolation and identification of new bacterial stains producing equol from Pueraria lobata extract fermentation. PLoS One 2018;13:e0192490.
49. Lee CC, Dudonńe S, Kim JH et al. A major daidzin metabolite 7,8,4'-trihydroxyisoflavone found in the plasma of soybean extract-fed rats attenuates monocyte-endothelial cell adhesion. Food Chem 2018a;240:607-14.
50. Lee DE, Lee KW, Jung SK et al. 6,7,4'-Trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2. Carcinogenesis 2011;32:629-35.
51. Lee H, Kim B-G, Ahn J-H. Production of bioactive hydroxyflavones by using monooxygenase from Saccharothrix espanaensis. J Biotechnol 2014;176:11-17.
52. Lee N, Lee S-H, Baek K et al. Heterologous expression of tyrosinase (MelC2) from Streptomyces avermitilis MA4680 in E. coli and its application for ortho-hydroxylation of resveratrol to produce piceatannol. Appl Microbiol Biot 2015;99: 7915-24.
53. Lee P-G, Kim J, Kim E-J et al. P212Amutant of dihydrodaidzein reductase enhances (S)-equol production and enantioselectivity in a recombinant Escherichia coli whole-cell reaction system. Appl Environ Microb 2016a;82:1992-2002.
54. Lee P-G, Kim J, Kim E-J et al. Biosynthesis of (-)-5-hydroxy-equol and 5-hydroxy-dehydroequol from soy isoflavone, genistein using microbial whole cell bioconversion. ACS Chem Biol 2017;12:2883-90.
55. Lee P-G, Lee S-H, Kim J et al. Polymeric solvent engineering for gram/liter scale production of a water-insoluble isoflavone derivative, (S)-equol. Appl Microbiol Biot 2018b;102: 6915-21.
56. Lee SH, Baek K, Lee JE et al. Using tyrosinase as a monophenol monooxygenase: A combined strategy for effective inhibition of melanin formation. Biotechnol Bioeng 2016b;113:735-43.
57. Lephart ED. Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms. Ageing Res Rev 2016;31:36-54.
58. Li M, Li H, Zhang C et al. Enhanced biosynthesis of Odesmethylangolensin from daidzein by a novel oxygentolerant cock intestinal bacterium in the presence of atmospheric oxygen. J Appl Microbiol 2015;118:619-28.
59. Maatooq GT, Rosazza JP. Metabolism of daidzein by Nocardia species NRRL 5646 and Mortierella isabellina ATCC 38063. Phytochemistry 2005;66:1007-11.
60. Matthies A, Blaut M, Braune A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microb 2009;75:1740-4.
61. Matthies A, Clavel T, Gütschow M et al. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microb 2008;74:4847-52.
62. Matthies A, Loh G, Blaut M et al. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr 2012;142:40-46.
63. Minamida K, Ota K, Nishimukai M et al. Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum. Int J Syst Evol Micr 2008;58:1238-40.
64. Minamida K, Tanaka M, Abe A et al. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. J Biosci Bioeng 2006;102:247-50.
65. Miyake M, Sano O, Iwaki K et al. Agent for enhancing the effect of skin-whitening ingredients and uses thereof: US20140205553A1, 2014.
66. Nakano M, Shibuya T, Miyake M et al. Whitening agent comprising equol or its saccharide derivative as an effective ingredient: US20100280231A1, 2010.
67. Nazir KNH, Ichinose H,Wariishi H. Construction and application of a functional library of cytochrome P450 monooxygenases from the filamentous fungus Aspergillus oryzae. Appl Environ Microb 2011;77:3147-50.
68. Niwa T, Yokoyama S-i, Matsugasaki N et al. Stereochemical determination of O-desmethylangolensin produced from daidzein. Food Chem 2015;171:153-6.
69. Pandey BP, Lee N, Choi K-Y et al. Screening of bacterial cytochrome P450s responsible for regiospecific hydroxylation of (iso)flavonoids. Enzyme Microb Technol 2011;48:386-92.
70. Pandey BP, Lee N, Choi K-Y et al. Identification of the specific electron transfer proteins, ferredoxin, and ferredoxin reductase, for CYP105D7 in Streptomyces avermitilis MA4680. Appl Microbiol Biot 2014a;98:5009-17.
71. Pandey BP, Roh C, Choi KY et al. Regioselective hydroxylation of daidzein using P450 (CYP105D7) from Streptomyces avermitilis MA4680. Biotechnol Bioeng 2010;105:697-704.
72. Pandey RP, Parajuli P, Koffas MA et al. Microbial production of natural and non-natural flavonoids: Pathway engineering, directed evolution and systems/synthetic biology. Biotechnol Adv 2016;34:634-62.
73. Pandey RP, Parajuli P, Koirala N et al. Glucosylation of isoflavonoids in engineered Escherichia coli. Mol Cells 2014b;37:172-7.
74. Park H-Y, Kim M, Han J. Stereospecific microbial production of isoflavanones from isoflavones and isoflavone glucosides. Appl Microbiol Biot 2011;91:1173-81.
75. Park J-S, Kim DH, Lee JK et al. Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors. Bioorg Med Chem Lett 2010;20:1162-4.
76. Park J-S, Park HY, Kim DH et al. ortho-Dihydroxyisoflavone derivatives from aged Doenjang (Korean fermented soypaste) and its radical scavenging activity. Bioorg Med Chem Lett 2008;18:5006-9.
77. Raimondi S, Roncaglia L, De Lucia M et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biot 2009;81:943-50.
78. Roh C, Choi K-Y, Pandey BP et al. Hydroxylation of daidzein by CYP107H1 from Bacillus subtilis 168. J Mol Catal B: Enzym 2009a;59:248-53.
79. Roh C, Seo S-H, Choi K-Y et al. Regioselective hydroxylation of isoflavones by Streptomyces avermitilis MA-4680. J Biosci Bioeng 2009b;108:41-46.
80. Rufer CE. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metab Dispos 2005;34:51-60.
81. Schoefer L, Mohan R, Braune A et al. Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 2002;208:197-202.
82. Schroder C, Matthies A, EngstWet al. Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microb 2013;79:3494-502.
83. Schwarzhans J-P, Luttermann T, Geier M et al. Towards systems metabolic engineering in Pichia pastoris. Biotechnol Adv 2017;35:681-710.
84. Schwen RJ, Nguyen L, Jackson RL. Elucidation of the metabolic pathway of S-equol in rat, monkey and man. Food Chem Toxicol 2012;50:2074-83.
85. Seo M-H, Kim B-N, Kim K-R et al. Production of 8-hydroxydaidzein from soybean extract by Aspergillus oryzae KACC 40247. Biosci Biotech Bioch 2013;77:1245-50.
86. Seo SG, Yang H, Shin SH et al. A metabolite of daidzein, 6,7,4'-trihydroxyisoflavone, suppresses adipogenesis in 3T3-L1 preadipocytes via ATP-competitive inhibition of PI3K. Mol Nutr Food Res 2013;57:1446-55.
87. Setchell KD. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001;20:354S-62S.
88. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - A clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577- 84.
89. Setchell KD, Brown NM, Zimmer-Nechemias L et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002;76:447-53.
90. Setchell KD, Clerici C, Lephart ED et al. S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005;81:1072-9.
91. Shaik S, Kumar D, de Visser SP et al. Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes. Chem Rev 2005;105:2279-328.
92. Shimada Y, Takahashi M, Miyazawa N et al. Identification of two novel reductases involved in equol biosynthesis in Lactococcus strain 20-92. J Mol Microb Biotech 2011;21:160- 72.
93. Shimada Y, Takahashi M, Miyazawa N et al. Identification of a Novel dihydrodaidzein racemase essential for biosynthesis of equol from daidzein in Lactococcus sp. strain 20-92. Appl Environ Microb 2012;78:4902-7.
94. Shimada Y, Yasuda S, Takahashi M et al. Cloning and expression of a novel NADP(H)-dependent daidzein reductase, an enzyme involved in the metabolism of daidzein, from equol-producing lactococcus strain 20-92. Appl EnvironMicrob 2010;76:5892-901.
95. Simons AL, Renouf M, Hendrich S et al. Metabolism of glycitein (7, 4'-dihydroxy-6-methoxy-isoflavone) by human gut microflora. J Agric Food Chem 2005;53:8519-25.
96. Tamura M, Hori S, Nakagawa H. Intestinal bacterium TM-30: An S-equol-producing bacterium isolated from human feces is involved in estrogen metabolism in vitro. Food Sci Technol Res 2014;20:309-16.
97. Tamura M, Tsushida T, Shinohara K. Isolation of an isoflavonemetabolizing, Clostridium-like bacterium, strain TM-40, from human faeces. Anaerobe 2007;13:32-35.
98. Tsangalis D, Ashton J, McGill A et al. Enzymic transformation of isoflavone phytoestrogens in soymilk by β-glucosidaseproducing Bifidobacteria. J Food Sci 2002;67:3104-13.
99. Tsangalis D,Wilcox G, Shah NP et al. Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br J Nutr 2005;93:867-77.
100. Tsuji H, Moriyama K, Nomoto K et al. Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS. Arch Microbiol 2010;192:279-87.
101. Tsuji H, Moriyama K, Nomoto K et al. Identification of an enzyme system for daidzein-to-equol conversion in Slackia sp. strain NATTS. Appl Environ Microb 2012;78:1228-36.
102. Tsuji H, Nomoto K, Moriyama K et al. Equol-producing bacterium and use thereof: US8420073B2, 2013.
103. Uchiyama S, Ueno T, Suzuki T. Composition containing lactic acid bacterium producing equol: US20060148045A1, 2006.
104. Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: A four-week study. J Am Coll Nutr 2002;21:97-102.
105. Umezawa H, Tobe H, Shibamoto N et al. Isolation of isoflavones inhibiting dopa decarboxylase from fungi and Streptomyces. J Antibiot 1975;28:947-52.
106. Urlacher VB, Girhard M. Cytochrome P450 monooxygenases: An update on perspectives for synthetic application. Trends Biotechnol 2012;30:26-36.
107. Wang H-j, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
108. Wang T-Y, Tsai Y-H, Yu I-Z et al. Improving 3'-hydroxygenistein production in recombinant Pichia pastoris using periodic hydrogen peroxide-shocking strategy. J Microbiol Biotechnol 2016;26:498-502.
109. Wang X-L, Hur H-G, Lee JH et al. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microb 2005;71:214-9.
110. Wang X-L, Kim H-J, Kang S-I et al. Production of phytoestrogen S-equol fromdaidzein in mixed culture of two anaerobic bacteria. Arch Microbiol 2007;187:155-60.
111. Wang XL, Kim K-T, Hur H et al. C-ring cleavage of isoflavones daidzein and genistein by a newly-isolated human intestinal bacterium Eubacterium ramulus Julong 601. J Microbiol Biotechnol 2004;14:766-71.
112. Wei P, Liu M, Chen Y et al. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med 2012;5:243-8.
113. Wei QK, Chen TR, Chen JT. Using of Lactobacillus and Bifidobacterium to product the isoflavone aglycones in fermented soymilk. Int J Food Microbiol 2007;117:120-4.
114. Williamson-Hughes PS, Flickinger BD, Messina MJ et al. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms. Menopause 2006;13:831-9.
115. Wu S-C, Chang C-W. Production of 8-hydroxygenistein through biotransformation by using Aspergillus oryzae. Chem Eng Commun 2016;203:1125-30.
116. Wu S-C, Chang C-W, Lin C-W et al. Production of 8-hydroxydaidzein polyphenol using biotransformation by Aspergillus oryzae. Food Sci Technol Res 2015;21:557-62.
117. Xie Y, Liu Z, Gao Y et al. Bioconversion of genistein to (-) 5-hydroxyequol by a newly isolated cock intestinal anaerobic bacterium. J Chin Pharm Sci 2015;24:442-8.
118. Yokoyama S-i, Niwa T, Osawa T et al. Characterization of an O-desmethylangolensin-producing bacterium isolated from human feces. Arch Microbiol 2010;192:15-22.
119. Yokoyama S-i, Oshima K, Nomura I et al. Complete genomic sequence of the O-desmethylangolensin-producing bacterium Clostridium rRNA cluster XIVa strain SY8519, isolated from adult human intestine. J Bacteriol 2011;193:5568-9.
120. Yokoyama S-i, Suzuki T. Isolation and characterization of a novel equol-producing bacterium from human feces. Biosci Biotech Bioch 2008;72:2660-6.
121. Yu Z-T, Yao W, Zhu W-Y. Isolation and identification of equolproducing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett 2008;282:73-80.
122. Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Mol Nutr Food Res 2007;51:765-81.
123. Zhao H, Wang X-L, Zhang H-L et al. Production of dihydrodaidzein and dihydrogenistein by a novel oxygen-tolerant bovine rumen bacterium in the presence of atmospheric oxygen. Appl Microbiol Biot 2011;92:803-13.
124. Zhou M, Hamza A, Zhan C-G et al. Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors. J Nat Prod 2013;76:279-86.